Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 147 of 155
-
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P118
-
In Marseille, Southern France, HLA-B2702 carries higher risk than HLA-B2705 to develop ankylosing spondylitis (AS)
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P105 -
The shared epitope revisited: shared epitope negative HLA-DR alleles influence susceptibility to rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P103 -
Follow-up study of the effect of a three-month course of ciprofloxacin on the late prognosis of reactive arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P101 -
Thymosin beta4 sylphoxide: potential role in resolution of inflammation?
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P099 -
Newer immunmodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P097 -
Induction of a rapid progessive cartilage destruction in SCID mice by intraarticular application of a murine fibroblast like cell line
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P095 -
Digital vasculitis in a patient with rheumatoid arthritis: good response on anti-TNF blockade
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P093 -
Development of a doxycycline inducible AAV vector for long term in vivo viral IL-10 gene transfer in rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P091 -
Serum levels of matrixmetalloproteinases MMP1 (collagenase) and MMP3 (stromelysin) before and after treatment with leflunamide in patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P089 -
Adenoviral gene transfer of tissue inhibitors of metalloproteinases (TIMPs) reduces the invasive behaviour of rheumatoid fibroblast-like synovicytes
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P087 -
Differences between active immunoinflammatory and postinfectious fibromyalgia (FM)
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P085 -
Isolation of β2GPI by perchloric acid yields three proteins having different antigenic properties
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P083 -
Impaired in vitro thrombin generation in β2-glycoprotein I null mice
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P079 -
Detection of bacterial components in synovial tissue from patients with inflammatory arthritis by using PCR with pan bacterial 23S rRNA and 16S rRNA primers, and gas chromatography-mass spectrometry
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P068 -
Fully competent dendritic cells as inducers of T cell anergy in autoimmunity
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P066 -
Autologous dendritic cells stimulate human HSP60 responsive T cells, in the absence of additional exogenous antigen
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P064 -
Effect of CD154-CD40 interactions on collagen production by fibroblasts
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P062 -
Signalling via T cell receptor (TCR) in patients with SLE
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P060 -
In vivo preactivated autoreactive Th cells in healthy individuals
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P058 -
Immune response to hn and snRNP in autoimmune mice. A model for the development of lupus autoimmunity by a single initiator T helper epitope?
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P056 -
Characterization of autoreactive T cells to the autoantigens hnRNP-A2/RA33 and filaggrin in patients with rheumatoid arthritis and controls
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P054 -
p205 induces the production of rheumatoid factors
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P052 -
Differences in B cell regulation in DRB1 shared epitope positive and negative rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P050 -
In vitro autoreactivity against autologous keratinocytes in patients with rheumatoid and juvenile idiopathic arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P048 -
MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P046 -
Specific suppression of the transcription factor AP-1 by mepacrine
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P044 -
A single nucleotide polymorphism on the IL-10 locus defines an expression polymorphism and a possible risk factor to develop RA
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P033 -
TNFa, IL10 and TGFb1 gene polymorphism in myositis and mixed connective tissue disease (MCTD)
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P031 -
Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P030 -
Inflammatory arthritis, hypoxia and vascularity
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P028 -
Comparison of arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P026 -
Temporal expression of cytokines and chemokines in rat adjuvant-induced arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P024 -
Interleukin-13 (IL-13)in autoimmune rheumatic diseases: relationship with autoantibody profile
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P022 -
The role of "nurse-like cells" in bone resorbtion observed in patients with RA
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L021 -
Human neutrophil production and cleavage of IL-18: potentiating inflammatory arthritis?
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P020 -
The pathogenesis of vasculitis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L019 -
High spontaneous CD40 expression by salivary gland epithelial cells in Sjogren's syndrome: possible evidence for intrinsic activation of epithelial cells
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P018 -
New approaches to inhibiting TNF production in rheumatoid arthritis: is pathological TNF regulated in the same way as protective TNF?
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L017 -
Elevated IL-16 level is a non-genetic characteristic of patients with severe systemic lupus erythematosus
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P016 -
Lysozyme and its biological value in rheumatoid arthritis (RA)
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P014 -
Anti-inflammatory activity of statins: potential use in the anti-phospholipid syndrome
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L013 -
Autoantibodies to the mRNA destabilizing protein hnRNP-D/AUF1 in patients with systemic autoimmune diseases
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P012 -
Gene expression analysis of Th1 and Th2 cells: clues to homing in inflammation
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L010 -
Correlation of the humoral immune answer to selected bacterial antigens with presence of the DNA specific to Salmonella enteritidis after amplification by PCR
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P010 -
Genetic analysis of the pentraxin genes in SLE
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L008 -
Investigation of the epitopes of human profilaggrin derived peptide targeted by antibodies of patient with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P008 -
DNA therapeutics: a feasible option for treatment of inflammatory diseases?
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L006 -
Protein microarray characterization of the autoantibody response in systemic lupus erythematosus and related diseases
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L002 -
Anti-keratin antibodies in juvenile idiopathic arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P001